SciELO - Scientific Electronic Library Online

vol.55 número2Extra Pulmonary Manifestations of SARS-CoV-2 Infection in Pediatrics. ReviewAssembling the Physiopathology Puzzle of COVID-19 índice de autoresíndice de assuntospesquisa de artigos
Home Pagelista alfabética de periódicos  

Serviços Personalizados




  • Não possue artigos citadosCitado por SciELO

Links relacionados

  • Não possue artigos similaresSimilares em SciELO


Anales de la Facultad de Ciencias Médicas (Asunción)

versão impressa ISSN 1816-8949


ARELLANO, Nelson et al. Major vascular resection for pancreatic ductal adenocarcinoma: case report, of first case reported in Paraguay. An. Fac. Cienc. Méd. (Asunción) [online]. 2022, vol.55, n.2, pp.97-104. ISSN 1816-8949.

Pancreatic ductal adenocarcinoma (PDA) is the fourth leading cause of cancer death and is projected to rank second by 2030. The prognosis is bleak, with survival being less than 9% in 5 years. For a long time, surgical resection was considered the only curative treatment, however, only 15 to 20% of patients can benefit from it. The most widely used pre-therapeutic classification is that of the National Comprehensive Cancer Network (NCCN), based on the relationship of the tumor with vascular structures, classifying them into “resectable”, “borderline” and “locally advanced” tumors. We present the first registered case in Paraguay of PDA with infiltration of the Superior Mesenteric Vein (SMV) treated with cephalic duodenopancreatectomy (CPD) associated with major vascular resection.

Palavras-chave : Pancreatic ductal adenocarcinoma; Resectable Pancreatic Cancer Borderline; Duodenopancreatectomy; Portal vein resection; neoadjuvant chemotherapy..

        · resumo em Espanhol     · texto em Espanhol     · Espanhol ( pdf )